ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,720,267 | +1.8% | 4,541 | -5.1% | 0.03% | -2.9% |
| Q3 2022 | $1,690,000 | -4.6% | 4,787 | +2.4% | 0.04% | +2.9% |
| Q2 2022 | $1,771,000 | +17.1% | 4,674 | -2.5% | 0.03% | +47.8% |
| Q1 2022 | $1,512,000 | +45.4% | 4,796 | +61.5% | 0.02% | +53.3% |
| Q4 2021 | $1,040,000 | +8.3% | 2,969 | -6.9% | 0.02% | 0.0% |
| Q3 2021 | $960,000 | 0.0% | 3,189 | 0.0% | 0.02% | +15.4% |
| Q2 2021 | $960,000 | +23.7% | 3,189 | +13.1% | 0.01% | +8.3% |
| Q1 2021 | $776,000 | -51.7% | 2,819 | -48.4% | 0.01% | -52.0% |
| Q4 2020 | $1,606,000 | +112.4% | 5,460 | +89.7% | 0.02% | +92.3% |
| Q3 2020 | $756,000 | – | 2,878 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |